p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck

British Journal of Cancer

Volumn 71, Issue 4, 1995, Pages 826-830

  Nylander, K ^a   Nilsson, P ^a   Mehle, C ^a   Roos, G ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cell proliferation; Head and neck; Mutation; P53; Squamous cell carcinoma

Indexed keywords

CYCLINE; IDOXURIDINE; PROTEIN P53;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE MUTATION; HEAD CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NECK CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; STOP CODON;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; EXONS; GENE EXPRESSION; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN P53; SEQUENCE DELETION; SUPPORT, NON-U.S. GOV'T; VARIATION (GENETICS);

EID: 0028953618     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.159     Document Type: Article

References (37)

1. AUDRfeZET MP, ROBASZKIEWICZ M, MERCIER B, NOUSBAUM JB, BAIL JP, HARDY E, VOLANT A, LOZACH P, CHARLES JF, GOUfe- ROU H AND FfcREC C. (1993). TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res., 53, 5745–5749.
2. BENNETT WP, HOLLSTEIN MC, HE A, ZHU SM, RESAU JH, TRUMP BF, METCALF RA, WELSH JA, MIDGLEY C, LANE DP AND HARRIS CC. (1991). Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6, 1779–1784.
3. BOYLE JO, HAKIM J, KOCH W, VAN DER RIET P, HRUBAN RH, ARTURO ROA R, CORREO R, EBY YJ, RUPPERT JM AND SID- RANSKY D. (1993). The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53, 4477–4480.
4. CAAMANO J, ZHANG SY, ROSVOLD EA, BAUER B AND KLEIN- SZANTO AJP. (1993). p53 alterations in human squamous cell carcinomas and carcinoma cell lines. Am. J. Pathol., 142, 1131–1139.
5. CESARMAN E, INGHIRAMI G, CHADBURN A AND KNOWLES DM. (1993). High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am. J. Pathol., 143, 845–856.
6. CHEN YT, XU L, MASSEY L, ZLOTOLOW IM, HUVOS AG, GARINCHESA P AND OLD LJ. (1994). Frameshift and nonsense p53 mutations in squamous cell carcinoma of head and neck - nonreactivity with three anit-p53 monoclonal antibodies. Int. J. Oncol., 4, 609–614.
7. ESRIG D, SPRUCK III, CH, NICHOLS PW, CHAIWUN B, STEVEN K, GROSHEN S, CHEN SC, SKINNER DG, JONES PA AND COTE RJ. (1993). p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumour grade, and stage in bladder cancer. Am. J. Pathol, 143, 1389–1397.
8. FIELD JK, SPANDIDOS DA, MALLIRI A, GOSNEY JR, YIGNISIS M AND STELL PM. (1991). Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br. J. Cancer, 64, 573–577.
9. FINLAY CA. (1993). Normal and malignant growth control by p53. In Oncogenes and Tumour Suppressor Genes in Human Malignancies, Benz CC and Liu ET (eds) pp. 327-344. Academic Publishers: Boston.
10. FREBOURG T AND FRIEND SH. (1993). The importance of p53 gene alterations in human cancers: Is there more than circumstantial evidence? J. Natl Cancer Inst., 85, 1554–1557.
11. GAIDANO G, BALLERINI P, GONG JZ, INGHIRAMI G, NERI A, NEWCOMB EW, MAGRATH IT, KNOWLES DM AND DALLA- FAVERA R. (1991). p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA, 88, 5413–5417.
12. HABUCHI T, TAKAHASHI R, YAMADA H, OGAWA O, KAKEHI Y, OGURA K, HAMAZAKI S, TOGUCHIDA J, ISHIZAKI K, FUJITA J, SUGIYAMA T AND YOSHIDA O. (1993). Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res., 53, 3795–3799.
13. HARRIS CC. (1993). p53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980–1981.
14. HSU HC, TSENG HJ, LAI PL, LEE PH AND PENG SY. (1993). Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumour growth and invasiveness. Cancer Res., 53, 4691–4694.
15. HUANG Y, MELTZER SJ, YIN J, TONG Y, CHANG EH, SRIVASTAVA S, MCDANIEL T, BOYNTON RF AND ZOU ZQ. (1993). Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res., 53, 1889–1894.
16. JOLLY KW, MALKIN D, DOUGLASS EC, BROWN TF, SINCLAIR AE AND LOOK A. (1994). Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene, 9, 97–102.
17. LANGDON JD AND PARTRIDGE M. (1992). Expression of the tumour suppressor gene p53 in oral cancer. Br. J. Oral Maxillofacial Surg., 30, 214–220.
18. LEVINE AJ, PERRY ME, CHANG A, SILVER A, DITTMER D, WU M AND WELSH D. (1994). The 1993 Walter Hubert lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer, 69, 409–416.
19. LEWIN B. (1990). Nuclear splicing junctions may be interchangeable. In: Genes IV, pp. 596-598. Oxford University Press: Oxford.
20. MCCORMICK D AND HALL PA. (1992). The complexities of proliferating cell nuclear antigen. Histopathology, 21, 591–594.
21. MACK DH, VARTIKAR J, PIPAS JM AND LAIMINIS LA. (1993). Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature, 363, 281–283.
22. MARCHETTI A, BUTTITTA F, PELLEGRINI S, CAMPANI D, DIELLA F, CECCHETTI D, CALLAHAN R AND BISTOCCHI M. (1993), p53 mutations and histological type of invasive breast carcinoma. Cancer Res., 53, 4665–4669.
23. MERCER WE, SHIELDS MT, LIN D, APPELLA E AND ULLRICH SJ. (1991). Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc. Natl Acad. Sci. USA, 88, 1958–1962.
24. MICHAUD J, BRODY LC, STEEL G, FONTAINE G, MARTIN LS, VALLE D AND MITCHELL G. (1992). Strand-separating conformational polymorphism analysis: Efficacy of detection of point mutations in the human ornithine ¿-aminotransferase gene. Genomics, 13, 389–394.
25. NYLANDER K, ANNEROTH G, GUSTAFSSON H, ROOS G, STEN-LING R AND ZACKRISSON B. (1994). Cell kinetics of head and neck squamous cell carcinomas, prognostic implications. Acta Oncol., 33, 23–28.
26. NYLANDER K, STENLING R, GUSTAFSSON H, ZACKRISSON B AND ROOS G. (1995). p53 expression and cell proliferation in squamous cell carcinomas of the head and neck region. Cancer (in press).
27. OLINER JD, PIETENPOL JA, THIAGALINGAM S, GYURIS J, KINZLER KW AND VOGELSTEIN B. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature, 362, 857–860.
28. ORITA M, SUZUKI Y, SEKIYA T AND HAYASHI K. (1989). Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874–879.
29. PERWEZ HUSSAIN S, AGUILAR F AND CERUTTI P. (1994). Mutagenesis of codon 248 of the human p53 tumour suppressor gene by N-ethyl-N-nitrosurea. Oncogene, 9, 13–18.
30. RUBIO MP, VON DEIMLIJ4G A, YANDELL DW, WIESTLER OD, GUSELLA JF AND LOUIS DN. (1993). Accumulation of wild type p53 protein in human astrocytomas. Cancer Res., 53, 3465–3467.
31. SHIBATA DK. (1992). The polymerase chain reaction and the molecular genetic analysis of tissue biopsies. In Diagnostic Molecular Pathology, a Practical Approach, Vol. II, Herrington CS and McGee JO’D (eds) pp. 85-111. Oxford University Press: Oxford.
32. SOMERS KD, MERRICK MA, LOPEZ ME, INCOGNITO LS, SCHECHTER GL AND CASEY G. (1992). Frequent p53 mutations in head and neck cancer. Cancer Res., 52, 5997–6000.
33. THORLACIUS S, BORRESEN AL AND EYFJORD JE. (1993). Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Cancer Res., 53, 1637–1641.
34. VOJTESEK B, BARTEK J, MIDGLEY CA AND LANE DP. (1992). An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods, 151, 237–244.
35. WAGATA T, SHIBAGAKI I, IMAMURA M, SHIMADA Y, TOGUCHIDA J, YANDELL DW, IKENAGA M, TOBE T AND ISHIZAKI K. (1993). Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res., 53, 846–850.
36. WU JK, YE Z AND DARRAS BT. (1993). Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumours with mixed cell populations. Am. J. Hum. Genet., 52, 1273–1275.
37. WYNFORD-THOMAS D. (1992). p53 in tumour pathology: can we trust immunocytochemistry? J. Pathol., 166, 329–330.